Contact
Please use this form to send email to PR contact of this press release:
KYAN Therapeutics Presents Preclinical Data on Novel HDACi Targeting KRAS-mutated Cancers at AACR-KCA Conference
TO:
Media Contact: Lisa Chow
Learn more at kyantherapeutics.com